Literature DB >> 15534057

Constancy and variability of gallbladder ejection fraction: impact on diagnosis and therapy.

Gerbail T Krishnamurthy1, Shakuntala Krishnamurthy, Paul H Brown.   

Abstract

UNLABELLED: The main objective of this study was to test the constancy and variability of gallbladder (GB) ejection fraction (EF) in long-term studies to (a) determine whether EF ever becomes normal once it is low, (b) determine how long it takes for the EF to become abnormal once it is found to be normal, (c) explore the cause of low EF, and (d) define objective parameters for biliary and nonbiliary abdominal pain.
METHODS: Fifty-two patients (42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mean period of 38.54 mo between studies, were chosen for retrospective analysis. They were divided into the following groups: control (n = 13; nonbiliary abdominal pain), chronic acalculous cholecystitis (CAC) (n = 27; biliary abdominal pain), chronic calculous cholecystitis (CCC) (n = 6; biliary abdominal pain), and opioid (n = 6; nonbiliary abdominal pain). The last group had received an opioid before cholecystokinin-8 (CCK-8) infusion in one study but not in the other study. A GBEF value of > or =35% was considered normal with a 3-min infusion and > or =50% as normal with a 10-min infusion of CCK-8.
RESULTS: The mean GBEF value was reproducible between the 2 sequential studies in the control group (66.0% +/- 20.5% vs. 73.9% +/- 17.7%), CAC group (24.4% +/- 22.3% vs. 16.9% +/- 10.9%), and CCC group (20.8% +/- 20.9% vs. 27.5% +/- 34.5%) but not in the opioid group (14.8% +/- 14.6% vs. 56.5% +/- 31.7%). The severity of GBEF reduction in CAC increased with time: 7.2% +/- 8.1% within 12 mo, 16.1% +/- 14.9% in 13-47 mo, and 23.5% +/- 21.3% in 48-168 mo. None of the 27 patients with CAC developed a gallstone as detected by ultrasound during the study period. In 5 patients with CAC, a mean period of 52.6 +/- 28.9 mo was required for conversion from normal to a low EF. CCK-induced cystic duct spasm is the etiology for low EF in both CAC and CCC.
CONCLUSION: Normal and low GBEF values are reproducible in long-term studies. Once the EF reaches a low value, it does not return to normal, and a normal value requires many years to become abnormal. CCK-induced cystic duct spasm is the cause of low GBEF in CAC and CCC, and the severity of EF reduction is similar for both. Exclusion of opioid intake immediately before the study is critical before attributing a low GBEF value to an irreversible GB motor dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534057

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Natural history of acalculous biliary symptoms.

Authors:  A M Warwick; F Bintcliffe; E Wu; D Stell
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

2.  Evaluation of gastrointestinal pathology and treatment in children with suspected biliary dyskinesia.

Authors:  Wikrom Karnsakul; Richard Vaughan; Tarun Kumar; Stacey Gillespie; Kathryn Skitarelic
Journal:  Pediatr Surg Int       Date:  2011-06-25       Impact factor: 1.827

Review 3.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

4.  Proton pump inhibitors reduce gallbladder function.

Authors:  M A Cahan; L Balduf; K Colton; B Palacioz; W McCartney; T M Farrell
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

5.  The cholecystokin provocation HIDA test: recreation of symptoms is superior to ejection fraction in predicting medium-term outcomes.

Authors:  Gareth Morris-Stiff; Gavin Falk; Laurel Kraynak; Steven Rosenblatt
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

6.  Reproducibility of gallbladder ejection fraction measured by Fatty meal cholescintigraphy.

Authors:  Kusai M Al-Muqbel; Mohammed N Bani Hani; Mwaffaq A Elheis; Ma'moon H Al-Omari
Journal:  Nucl Med Mol Imaging       Date:  2010-10-13

Review 7.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Diagnostic stringency and healthcare needs in patients with biliary dyskinesia.

Authors:  Nitin Aggarwal; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2013-08-11       Impact factor: 3.199

9.  Role of laparoscopic cholecystectomy in the management of chronic right upper quadrant pain due to biliary dyskinesia: a systematic review and meta-analysis.

Authors:  Saad Rehman; Krishna Kumar Singh; Muhammad Shafique Sajid
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-23

10.  The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.

Authors:  Lee S Rosen; Lara Lipton; Timothy J Price; Neil D Belman; Ralph V Boccia; Herbert I Hurwitz; Joe J Stephenson; Lori J Wirth; Sheryl McCoy; Yong-Jiang Hei; Cheng-Pang Hsu; Niall C Tebbutt
Journal:  BMC Cancer       Date:  2013-05-16       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.